Most Read Articles
Roshini Claire Anthony, 4 days ago

Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.

Tristan Manalac, 5 days ago
Users of electronic nicotine delivery systems are likely to have received a diagnosis of clinical depression in the past, according to a recent study.
Pearl Toh, 06 Dec 2019
Getting just under one extra hour of sleep per night can go a long way for the health of college students, who are often sleep-deprived, a study suggests.
Jairia Dela Cruz, 3 days ago
Use of isatuximab (Isa) in combination with pomalidomide and dexamethasone (PomDex) appears to lead to more favourable outcomes in elderly patients with relapsed/refractory multiple myeloma (RRMM) as compared with PomDex alone, according to the results of a subgroup analysis of the ICARIA-MM trial presented at the 61st Annual Meeting of the American Society of Hematology (ASH 2019).

Pharmacy-led counselling in a dermatology centre cuts smoking rates

Stephen Padilla
28 Feb 2019
Killing two birds with one stone: Smokers struggling to quit – who might also be considering cosmetic surgery – may just find a ‘solution’ to help kick the smoking habit through a nip and tuck op.

Results of a Singapore study have shown the effectiveness of a structure pharmacist-led cessation counselling in reducing smoking rates. Smoking cessation can thus be made a part of the holistic management of dermatological conditions.

“Given the adverse effects of smoking on the skin and the importance of stressing on physical appearance for behavioural modification, dermatological clinics represent a unique opportunity and effective platform for clinicians to engage patients in the cessation or reduction of cigarette smoking,” researchers said.

This single-centre, retrospective study identified 74 current smokers who received counselling at a structured smoking cessation clinic. Researchers collected information on baseline demographic characteristics and detailed past medical history, including smoking history, and conducted follow-up at 2 weeks and 3 months.

Of the 57 patients who were assessed at 2 weeks, nine (15.8 percent) had stopped smoking and 26 (45.6 percent) reduced the number of cigarettes they smoked per day (mean reduction, 4.1 cigarettes per day). [Singapore Med J 2019;60:31-33]

On the other hand, there were also a few patients who did not change habits or even increased the number of cigarette sticks smoked per day following counselling.

“Our results showed that smoking cessation intervention at a dermatology clinic was effective,” researchers said.

A local study at a restructured government hospital reported quit rates of 27.3 percent and 23.1 percent at 3 months of participation in the inpatient and outpatient smoking cessation programmes, respectively. In a recent Cochrane review, results showed a quit rate of 18–21 percent, depending on whether behavioural support was administered with pharmacotherapy. [Ann Acad Med Singapore 2012;41:230-232; Cochrane Database Syst Rev 2015;10:CD009670]

“Comparatively, in our study, 33.3 percent of participants ceased smoking and 22.2 percent had a reduction of cigarettes smoked at 3 months,” researchers said.

A previous study by Thompson and colleagues found the following factors to be associated with lower attrition rates: older participant age, being followed up by telephone call, smoking relapse or failure to reduce smoking levels. [Trials 2016;17:524]

Thompson suggested that to reduce dropout rates in future studies, “strategies to engage younger participants should be followed and reassurances given to participants that smoking behaviour should not influence ongoing participation in the study.” In addition, when following up participants through phone calls, researchers should work flexible hours, so that those who are employed can be contacted during regular working hours. [Trials 2016;17:524]

In the present study, fees for follow-up appointment were reduced to ease the financial load. Participants were also counselled that attending at least one follow-up was mandatory.

“Increasingly, more pharmacists are being trained to run the programme and doctors will receive prompts on the computer during consultation with participants, so that they can play a more constructive and hands-on role in motivational interviewing as well as encouraging compliance with treatment and follow-up,” researchers said.

“Cigarette smoking is a leading cause of morbidity and mortality and has a deleterious effect on dermatological conditions, such as skin cancers, hidradenitis suppurativa and psoriasis,” they noted.

Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.

Tristan Manalac, 5 days ago
Users of electronic nicotine delivery systems are likely to have received a diagnosis of clinical depression in the past, according to a recent study.
Pearl Toh, 06 Dec 2019
Getting just under one extra hour of sleep per night can go a long way for the health of college students, who are often sleep-deprived, a study suggests.
Jairia Dela Cruz, 3 days ago
Use of isatuximab (Isa) in combination with pomalidomide and dexamethasone (PomDex) appears to lead to more favourable outcomes in elderly patients with relapsed/refractory multiple myeloma (RRMM) as compared with PomDex alone, according to the results of a subgroup analysis of the ICARIA-MM trial presented at the 61st Annual Meeting of the American Society of Hematology (ASH 2019).